1. Home
  2. AGIO vs TDC Comparison

AGIO vs TDC Comparison

Compare AGIO & TDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGIO
  • TDC
  • Stock Information
  • Founded
  • AGIO 2007
  • TDC 1979
  • Country
  • AGIO United States
  • TDC United States
  • Employees
  • AGIO N/A
  • TDC N/A
  • Industry
  • AGIO Biotechnology: Pharmaceutical Preparations
  • TDC Computer Software: Prepackaged Software
  • Sector
  • AGIO Health Care
  • TDC Technology
  • Exchange
  • AGIO Nasdaq
  • TDC Nasdaq
  • Market Cap
  • AGIO 3.0B
  • TDC 3.2B
  • IPO Year
  • AGIO 2013
  • TDC 2007
  • Fundamental
  • Price
  • AGIO $55.68
  • TDC $30.67
  • Analyst Decision
  • AGIO Buy
  • TDC Hold
  • Analyst Count
  • AGIO 7
  • TDC 11
  • Target Price
  • AGIO $52.33
  • TDC $36.40
  • AVG Volume (30 Days)
  • AGIO 740.7K
  • TDC 1.0M
  • Earning Date
  • AGIO 10-31-2024
  • TDC 11-04-2024
  • Dividend Yield
  • AGIO N/A
  • TDC N/A
  • EPS Growth
  • AGIO N/A
  • TDC 41.17
  • EPS
  • AGIO 11.80
  • TDC 0.84
  • Revenue
  • AGIO $32,871,000.00
  • TDC $1,798,000,000.00
  • Revenue This Year
  • AGIO $33.38
  • TDC N/A
  • Revenue Next Year
  • AGIO $163.06
  • TDC N/A
  • P/E Ratio
  • AGIO $4.72
  • TDC $36.61
  • Revenue Growth
  • AGIO 36.79
  • TDC N/A
  • 52 Week Low
  • AGIO $20.96
  • TDC $24.02
  • 52 Week High
  • AGIO $62.58
  • TDC $49.44
  • Technical
  • Relative Strength Index (RSI)
  • AGIO 62.44
  • TDC 52.62
  • Support Level
  • AGIO $52.09
  • TDC $28.63
  • Resistance Level
  • AGIO $62.58
  • TDC $30.02
  • Average True Range (ATR)
  • AGIO 2.91
  • TDC 0.89
  • MACD
  • AGIO -0.11
  • TDC 0.01
  • Stochastic Oscillator
  • AGIO 64.30
  • TDC 92.22

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

About TDC Teradata Corporation

Teradata Corp provides analytic data products and related services. The Company operates in data and analytics, which captures, integrates, stores, manages, and analyzes data of all types to answer business questions and deliver insight; and marketing applications, which offer marketing management products to help businesses win customer loyalty. Its solutions include components such as data warehousing, Asset optimization, Fraud prevention, Product innovation, and risk mitigation. A majority of the firm's revenue is generated in the United States.

Share on Social Networks: